Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease
about
sameAs
Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmissionPromising biological therapies for ulcerative colitis: A review of the literatureShining a light on intestinal trafficMeta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitisExpression of mucosal addressin cell adhesion molecule 1 on vascular endothelium of gastric mucosa in patients with nodular gastritisMechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cellsDetection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasoundUnsupervised Analysis of Array Comparative Genomic Hybridization Data from Early-Onset Colorectal Cancer Reveals Equivalence with Molecular Classification and Phenotypes.Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis.Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis.Mechanisms of lymphocyte migration in autoimmune disease.Lymphocyte homing and its role in the pathogenesis of IBD.GlcNAc6ST-1-mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitisPharmacological characterization of PF-00547659, an anti-human MAdCAM monoclonal antibodyDendritic cells in intestinal homeostasis and disease.Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis.Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation.Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?Homing of immune cells: role in homeostasis and intestinal inflammation.Development and application of endothelium-targeted microparticles for molecular magnetic resonance imaging.Modifying T-cell trafficking to the intestinal as a potential management for inflammatory bowel disease.What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails?Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target.The role of glycosylation in IBD.Vedolizumab: first global approval.Biological therapy for ulcerative colitis: an update.Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice.CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease.Systematic review and meta-analysis: opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease.Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.The genetic burden of inflammatory bowel diseases: implications for the clinic?Genetic risk variants as therapeutic targets for Crohn's disease.New and emerging treatments for ulcerative colitis: a focus on vedolizumab.Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases.Dysregulated circulating dendritic cell function in ulcerative colitis is partially restored by probiotic strain Lactobacillus casei ShirotaEffect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.Indium-labelled human gut-derived T cells from healthy subjects with strong in vitro adhesion to MAdCAM-1 show no detectable homing to the gut in vivo.Serum interleukin-6 level is associated with response to infliximab in ulcerative colitis.
P2860
Q21090622-1952CEA8-D9A9-4353-A6A9-FED9020CBBDFQ26776139-F5B71777-D856-446C-9F98-DC69C591662EQ26863227-7AE4B22D-1D61-439D-AACD-6069439DF207Q28080984-213FE61E-A95B-49AA-A198-021038A881D5Q28190845-41C91D86-4A00-4BC0-A465-828C4C17F2D5Q28287701-09B04572-9AC2-4F1E-962B-34BD61A95D24Q30356090-98E2C001-DA82-434D-AB40-2F20183C413EQ31149689-6D46AAC6-3D53-47BC-AC61-0390C06E5303Q33897813-51AFF91A-59CC-497C-B50F-1E27DD9DB40BQ34622765-CFB5DABD-EB65-4701-9C1F-6E3FB9801088Q36230730-920FAF79-1A07-4D7A-957A-BE1DD7AA1301Q37130397-2ADA477B-C212-46F8-ABED-1D25F551A72CQ37228128-D0EAF35B-1944-4571-A8CB-E5516DFE1C8BQ37230907-96633AB9-FA41-44EE-9420-57BFB2ED5426Q37591719-4B9424B6-A866-4936-88C5-1E3563053A0BQ37691599-ECB4C3CA-E091-4132-8E62-8092EBCC4631Q37707264-763A2B5E-C8AB-4831-A885-9E86A3AE2CDBQ37762230-A97DCE6A-B00D-476E-8371-0612064BC3FDQ37789685-22ADF178-2792-486A-90A0-60629708CD9CQ37992560-917C053C-D81A-4264-B756-369CD12DFB50Q38011773-38A7C1DE-5ED4-4A9B-84D2-988767321C30Q38191583-8B9B653F-E48C-455A-B80E-AF0F87EB8D5EQ38210630-A5A15E5A-474C-4D97-9540-71C7B88CF08DQ38218832-31E35C25-E7CE-4E12-9832-385944B77ADBQ38225389-6B497264-B669-4928-81C5-65C6E8ABCEB1Q38259532-1021A128-CD0F-4480-A060-8F1AD8736C5DQ38341042-D54F6AB6-4E1A-41BC-B7D6-8D3918BB2E14Q38432470-06ED6046-5D29-4A4D-84F3-CF39C56BDDFAQ38436580-D1A68544-9159-4425-B4EA-C7F9BE8E03EEQ38630959-AC42A173-3552-49E0-8950-2B27F3BE5151Q38858574-969B5393-4B87-4D87-AF27-FCCF8E4F9796Q38915139-D9E36869-ECCE-40D0-9901-F74D5904ECCEQ41149278-B5F3D910-9DFF-4DB7-A231-BBA444F3E92CQ41661113-0EDE83A3-99D5-487A-A531-262624EFCECFQ41813088-EEDD0A3C-6DA8-4DEE-A366-208E5D89BFAEQ41900677-938307D8-4EC4-4189-A215-24925093E1BEQ42278326-06F04DB0-789B-458C-98C7-7211695BF0F8Q44117944-776F0EE6-44E8-4A87-B46C-CAFCD41C58E6Q45063507-6752FF44-2EC8-4CFE-9B68-7519B881BABBQ49682864-ECBE57B6-328B-4232-BEF5-3A73AEC2CA64
P2860
Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn's disease
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Differential expression of muc ...... ve colitis and Crohn's disease
@ast
Differential expression of muc ...... ve colitis and Crohn's disease
@en
Differential expression of muc ...... ve colitis and Crohn's disease
@nl
type
label
Differential expression of muc ...... ve colitis and Crohn's disease
@ast
Differential expression of muc ...... ve colitis and Crohn's disease
@en
Differential expression of muc ...... ve colitis and Crohn's disease
@nl
prefLabel
Differential expression of muc ...... ve colitis and Crohn's disease
@ast
Differential expression of muc ...... ve colitis and Crohn's disease
@en
Differential expression of muc ...... ve colitis and Crohn's disease
@nl
P2093
P2860
P1476
Differential expression of muc ...... ve colitis and Crohn's disease
@en
P2093
Akira Torii
Chieko Ejima
Gotaro Toda
Haruo Ohtani
Hiroshi Nagura
Iwao Sasaki
Kouhei Fukushima
Manabu Suzuki
Masahiro Murata
Motoji Oki
P2860
P304
P356
10.1046/J.1440-1827.2002.01365.X
P407
P577
2002-01-01T00:00:00Z